Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Intervention of Obesity in Children With Prader-Willi Syndrome Using Prebiotics and Probiotics
Sponsor: Children's Hospital of Fudan University
Summary
Prader-Willi syndrome (PWS) is a rare genetic disease, with hyperappetite and severe obesity. At present, there is no effective drugs and interventions to help control the appetite of PWS patients. More and more evidence has shown that gut microbiota is closely related to obesity. Probiotics and prebiotics can improve the structure of gut microbiota, thus improve blood lipid levels and other biochemical indicators of obese people. Therefore, this study intends to explore the effectiveness and safety of probiotics and prebiotics in controlling appetite and weight gain of PWS children.
Official title: The Safety and Effectiveness Study of Prebiotics and Probiotics in the Intervention of Obesity in Children With Prader-Willi Syndrome
Key Details
Gender
All
Age Range
3 Years - 10 Years
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2023-04-01
Completion Date
2026-07-31
Last Updated
2026-03-27
Healthy Volunteers
No
Conditions
Interventions
probiotics including B. lactis B420, B. lactis HN019, B. animalis Bb-12, L. rhamnosus GG
Take probiotics, 2g each time, twice a day, for 12 weeks
Prebiotics with galactomannan and oligofructose
Take probiotics, 2g each time, twice a day, for 12 weeks Take prebiotics, 25g each time, twice a day, for 12 weeks
Locations (1)
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, China